This week the Australian Therapeutic Goods Administration (TGA) has granted Moderna provisional approval for their vaccine for 6 months to 5yr olds. We analyse the KidCOVE study of 7200 children they used to justify the approval and compare it to a recent study out of Singapore on vaccine efficacy against Omicron of 250,000 kids aged 5-11. We also talk about climate alarmism, Australia's national debt and why businesses need to be allowed to fail.
